Cytek Biosciences Inc. (CTKB) Revenue Analysis | Historical Sales Growth & Trends - Stocknear

Cytek Biosciences Inc.

NASDAQ: CTKB · Real-Time Price · USD
4.02
0.04 (1.01%)
At close: Sep 05, 2025, 3:59 PM
4.02
0.00%
After-hours: Sep 05, 2025, 04:42 PM EDT

Cytek Biosciences Revenue

Cytek Biosciences reported an annual revenue of $200.45M, reflecting a 3.85% growth. For the quarter ending June 30, 2025, Cytek Biosciences generated $45.6M in revenue.
Revenue (ttm)
200.45M
Revenue Growth
3.85%
Price / Sales Ratio
4.23
Revenue / Employee
302.34K
Employees
663
Market Cap
511.44M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 200.45M +3.85%
Dec 31, 2023 193.01M +17.67%
Dec 31, 2022 164.04M +28.20%
Dec 31, 2021 127.95M +37.82%
Dec 31, 2020 92.84M +60.39%
Dec 31, 2019 57.88M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.